Captor Therapeutics Competitors and Similar CompaniesClear all
Captor Therapeutics's competitors and similar companies include CureVac and Biocon.
 Captor Therapeutics Captor Therapeutics is a biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 2000 | Founding Date 1978 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Wrocław, PL HQ Allschwil, CH | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more |
Employees | Employees 88 | Employees 82517% decrease | Employees 16,5612% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) ₹167.8b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods ₹56.9b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit ₹115.8b (FY, 2026) |
Net income | Net income N/A | Net income €162.2m (FY, 2024) | Net income ₹3.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View company